Protein kinase C inhibition induces DNA fragmentation in COLO 205 cells which is blocked by cysteine protease inhibition but not mediated through caspase-3

Experimental Cell Research

Volumn 289, Issue 1, 2003, Pages 1-10

  Lewis, Aurélia E ^a,b   Wong, Benjamin C Y ^a,c   Langman, Michael J S ^a   Eggo, Margaret C ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Caspase 3; Colonocytes; Cysteine protease; Protein kinase C

Indexed keywords

ALOXISTATIN; CASPASE 3; CYSTEINE PROTEINASE; DNA FRAGMENT; PROTEIN KINASE C; THYMIDINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0043164778     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00219-2     Document Type: Article

References (43)

1. Kuranami M., Powell C.T., Hug H., Zeng Z., Cohen A.M., Guillem J.G. Differential expression of protein kinase C isoforms in human colorectal cancers. J. Surg. Res. 58:1995;233-239.
2. Kahl-Rainer P., Karner-Hanusch J., Weiss W., Marian B. Five or six protein kinase C isoenzymes present in normal mucosa show reduced protein levels during tumor development in the human colon. Carcinogenesis. 15:1994;779-782.
3. 2+ -dependent protein kinases in human colon carcinomas. Cancer Res. 47:1987;2036-2039.
4. Levy M.F., Poscidio J., Guillem J.G., Forde K., LoGerfo P., Weinstein I.B. Decreased levels of protein kinase C activity and protein kinase C mRNA in primary colon tumors. Dis. Colon Rectum. 36:1993;913-921.
5. Weller S.G., Klein I.K., Pennington R.C., Karnes W.E. Distinct protein kinase C isozymes signal mitogenesis and apoptosis in human colon cancer cells. Gastroenterology. 117:1999;848-857.
6. De Vente J., Kiley S., Garris T., Bryant W., Hooher J., Posekany K., Parker P., Cook P., Fletcher D., Ways D.K. Phorbol ester treatment of U937 cells with altered protein kinase C content and distribution induces cell death rather than differentiation. Cell Growth Diff. 6:1995;371-382.
7. Freemerman A.J., Turner A.J., Birrer M.J., Szabo E., Valerie K., Grant S. Role of c-jun in human myeloid leukemia cell apoptosis induced by pharmacological inhibitors of protein kinase C. Mol. Pharmacol. 49:1996;788-795.
8. Begemann M., Kashimawo S.A., Choi Y.-J.A., Kim S., Christiansen K.M., Duigou G., Mueller M., Schieren I., Ghosh S., Fabbro D., Lampen N.M., Heitjan D.F., Schiff P.B., Bruce J.N., Weinstein I.B. Inhibition of growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by phorbol ester tumor promoter. Clin. Cancer Res. 2:1996;1017-1030.
9. Leszezynski D. The role of protein kinase C in regulation of apoptosis a brief overview of the controversy . Cancer J. 9:1996;308-313.
10. Newton A. Regulation of protein kinase C. Curr. Opin. Cell. Biol. 9:1997;161-167.
11. Gruenberg J., Clague M.J. Regulation of intracellular membrane transport. Curr. Opin. Cell. Biol. 4:1992;593-599.
12. Lu Z., Liu D., Hornia A., Devonish W., Pagano M., Foster D.A. Activation of protein kinase C triggers its ubiquitination and degradation. Mol. Cell. Biol. 18:1998;839-845.
13. Cheng E.H.-Y., Kirsch D.G., Clem R.J., Ravi R., Kastan M.B., Bedi A., Ueno K., Hardwick J.M. Conversion of Bcl-2 to a Bax-like effector by caspases. Science. 278:1997;1196-1966.
14. Enari, M., Sakahira, H., Yakoyama, H., Okawa, K., Iwamatsu, A., Nagata, S.A., Caspase activated DNAase that degrades DNA during apoptosis and its inhibitor ICAD. Nature 391, 43-50.
15. Shao R.-G., Shimizu T., Pommier Y. Activation of PKCα downstream from caspases during apoptosis induced by 7-hydroxystaurosporine or the topoisomerase inhibitors, camptothecin and etoposide, in human myeloid leukemia HL60 cells. Exp. Cell Res. 234:1997;388-397. doi:10.1006/excr.1997.3650.
16. Emoto Y., Manome Y., Meinhardt G., Kisaki H., Kharbanda S., Robertson M., Ghayur T., Wong W.W., Kamen R., Weichselbaum R., Kufe D. Proteolytic activation of protein kinase C δ by an ICE-like protease in apoptotic cells. EMBO J. 14:1995;6148-6156.
17. Datta R., Kojima H., Yoshida K., Kufe D. Caspase 3-mediated cleavage of protein kinase C theta in induction of apoptosis. J. Biol. Chem. 272:1997;20317-20320.
18. Frutos S., Moscat J., Diaz-Mecp M.T. Cleavage of zeta PKC but not lambda PKC by caspase-3 during UV-induced apoptosis. J. Biol. Chem. 274:1999;10765-10770.
19. Schotte P., Declercq W., Van Huffel S., Vandenabeele P., Beyaert R. Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett. 442:1999;117-121.
20. Leist M., Jaattela M. Four deaths and a funeral from caspases to alternative mechanisms . Nat. Rev. Mol. Cell. Biol. 2:2001;589-598.
21. Semple T.U., Quinn L.A., Woods L.K., Moore G.E. Tumor and lymphoid cell lines derived from a patient with carcinoma of the colon for a cytotoxicity model. Cancer Res. 38:1978;1345-1355.
22. Herbert J.M., Augerlau J.M., Gleye J., Maffrand J.P. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172:1990;993-999.
23. Nixon J.S., Bishop J., Bradshaw D., Davis P.D., Hill C.H., Elliot L.H., Kumar H., Lawton G., Lewis E.J., Mulqueen M., Westmacott D., Wadsworth J., Wilkinson S.E. The design and biological properties of potent and selective inhibitors of protein kinase C. Biochem. Soc. Trans. 20:1992;419-425.
24. Wilkinson S.E., Parker P.J., Nixon J.S. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem. J. 294:1993;335-337.
25. Isahara K., Ohsawa Y., Kanamori S., Shibata M., Waguri S., Sato N., Gotow T., Watanabe T., Momoi T., Urase K., Kominami E., Uchiyama Y. Regulation of a novel pathway for cell death by lysosomal aspartic and cysteine proteinases. Neuroscience. 91:1999;233-249.
26. Nishizuka Y. Studies and perspective of protein kinase C. Science. 233:1986;305-312.
27. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9:1995;484-496.
28. Yu R., Mandlekar S., Tan T.-H., Kong A.-N. Activation of p38 and c-jun N-terminal kinase pathways and induction of apoptosis by chelerythrine do not require inhibition of protein kinase C. J. Biol. Chem. 275:2000;9612-9619.
29. Beltman J., McCormick F., Cook S.J. The selective protein kinase C inhibitor, Ro-31-8220, inhibits mitogen-activated protein kinase phosphatase-1 (MKP-1) expression, induces c-Jun expression, and activates Jun N-terminal kinase. J. Biol. Chem. 271:1996;27018-27024.
30. Gnesutta N., Qu J., Minden A. The serine/threonine kinase PAK4 prevents caspase activation and protect cells from apoptosis. J. Biol. Chem. 276:2001;14414-14419.
31. Li L.Y., Luo X., Wang X. Endonuclease G is an apoptotic DNAase when released from mitochondria. Nature. 412:2001;95-99.
32. Torriglia A., Negri C., Chaudun E., Prospri E., Courtois Y., Counis M.F., Scovassi A. I. Differential involvement of DNAses in Hela cell apoptosis induced by etoposide and long term-culture. Cell Death Diff. 6:1999;234-244.
33. Villa P.G., Henzel W.J., Sensenbrenner M., Henderson C.E., Pettmann B. Calpain inhibitors, but not caspase inhibitors, prevent actin proteolysis and DNA fragmentation during apoptosis. J. Cell Sci. 111:1998;713-722.
34. Ariyoshi H., Shiba E., Kambayshi J., Sakon M., Tsujinaka T., Uemura T., Mori T. Characteristics of various synthetic peptide calpain inhibitors and their application for the analysis of platelet reaction. Biochem. Int. 23:1991;1019-1033.
35. Shinohara K., Tomioka M., Nakano H., Toné S., Ito H., Kawashima S. Apoptosis induction resulting from proteasome inhibition. Biochem. J. 317:1996;385-388.
36. Kitagawa H., Tani E., Ikemoto H., Ozaki I., Nakano A., Omura S. Proteasome inhibitors induce mitochondria-independent apoptosis in human glioma cells. FEBS Lett. 443:1999;181-186.
37. Drexler H.C.A. Activation of the cell death program by inhibition of proteasome function. Proc. Natl. Acad. Sci. USA. 94:1997;855-860.
38. Shuja S., Sheahan K., Murnane M.J. Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas. Int. J. Cancer. 49:1991;341-346.
39. Herszenyi L., Plebani M., Carraro P., DePaoli M., Roveroni G., Cardin R., Tulassay Z., Naccarato R., Farinati F. The role of cysteine and serine proteases in colorectal carcinoma. Cancer. 86:1999;1135-1142.
40. Keppler D., Waridel P., Abrahamson M., Bachmann D., Berdoz J., Sordat B. Latency of cathepsin B secreted by human colon carcinoma cells is not linked to secretion of cystatin C and is relieved by neutrophil elastase. Biochim. Biophys. Acta. 1226:1994;117-125.
41. Leist M., Jäättelä M. Triggering of apoptosis by cathepsins. Cell Death Diff. 8:2001;324-326.
42. Turk B., Turk D., Turk V. Lysosomal cystein proteases more than scavengers . Biochim. Biophys. Acta. 1477:2000;98-111.
43. Foghsgaard L., Wissing D., Mauch D., Lademann U., Bastholm L., Boes M., Elling F., Leist M., Jäättelä M. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor, J. Cell Biol. 153:2001;999-1009.